Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Shares Issued (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Shares Issued for 4 consecutive years, with $91000.0 as the latest value for Q1 2025.

  • Quarterly Shares Issued rose 405.56% to $91000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $91000.0 through Dec 2025, down 99.39% year-over-year, with the annual reading at $91000.0 for FY2025, 99.39% down from the prior year.
  • Shares Issued for Q1 2025 was $91000.0 at Orchestra BioMed Holdings, down from $14.8 million in the prior quarter.
  • The five-year high for Shares Issued was $14.8 million in Q4 2024, with the low at -$55000.0 in Q4 2023.
  • Average Shares Issued over 4 years is $1.4 million, with a median of $42000.0 recorded in 2022.
  • The sharpest move saw Shares Issued plummeted 98.65% in 2023, then skyrocketed 27092.73% in 2024.
  • Over 4 years, Shares Issued stood at $42000.0 in 2022, then crashed by 230.95% to -$55000.0 in 2023, then surged by 27092.73% to $14.8 million in 2024, then crashed by 99.39% to $91000.0 in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $91000.0, $14.8 million, and $171000.0 for Q1 2025, Q4 2024, and Q2 2024 respectively.